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Objective: Genome-wide association studies (GWAS) of BMI are mostly undertaken under the assump-
tion that “kg/m2” is an index of weight fully adjusted for height, but in general this is not true. The aim
here was to assess the contribution of common genetic variation to a adjusted version of that phenotype
which appropriately accounts for covariation in height in children.
Methods: A GWAS of height-adjusted BMI (BMI[x]5weight/heightx), calculated to be uncorrelated with
height, in 5809 participants (mean age 9.9 years) from the Avon Longitudinal Study of Parents and Chil-
dren (ALSPAC) was performed.
Results: GWAS based on BMI[x] yielded marked differences in genomewide results profile. SNPs in ADCY3
(adenylate cyclase 3) were associated at genome-wide significance level (rs11676272 (0.28 kg/m3.1 change
per allele G (0.19, 0.38), P56 3 1029). In contrast, they showed marginal evidence of association with con-
ventional BMI [rs11676272 (0.25 kg/m2 (0.15, 0.35), P56 3 1027)]. Results were replicated in an independ-
ent sample, the Generation R study.
Conclusions: Analysis of BMI[x] showed differences to that of conventional BMI. The association signal
at ADCY3 appeared to be driven by a missense variant and it was strongly correlated with expression of
this gene. Our work highlights the importance of well understood phenotype use (and the danger of con-
vention) in characterising genetic contributions to complex traits.
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Introduction
BMI (weight(kg)/height(m2)) has become a uniformly used measure
of weight given height despite being defined in the 19th century
based only on population specific knowledge at the time (1). As an
index of weight for height it ought to be uncorrelated with height,
but in practice it is not. This complicates its biological interpretation
as the correlation between BMI and height varies across different
age groups, body types and ethnicities (2,3). Different power terms
[x] for height are required in the calculation of BMI in men and
women and across different age groups and ethnicities to achieve
maximum correlation with total body fat measured by Dual-energy
X-ray absorptiometry (DXA) and minimum correlation with height
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(4). In addition, BMI is considered a measure of adiposity although
it is particularly inaccurate for measuring adiposity in individuals
with elevated lean body mass, such as athletes (5). BMI has been
found previously not to be appropriate for children later in child-
hood, as the formula of weight(kg)/height(m2)) overestimates the
BMI of tall or physically advanced children (6). Dividing BMI by
the appropriate power of height as a function of the child’s age was
suggested as the best way to assess adiposity in children (6). How-
ever, the genetic profiles of BMI versus suggested alternative meas-
urements of adiposity in children have not been assessed.
Phenotypic refinement is important in the undertaking of informative and
well powered GWAS. Not only can the use of more biologically proxi-
mal measurements reduce the level of noise associated with any given
genetic association signal, but the redefinition of a routine measurement
can yield marked differences in genetic profile. A clear example of this
was seen in the publication of the now well-known association between
variation at FTO and fat mass (7,8). Initially, FTO was discovered as a
type 2 diabetes (T2D) locus, as reported in an association study for T2D
in the absence of BMI matching in cases and controls (9). The combina-
tion of study design and phenotypic refinement allowed for the demon-
stration that FTO was exerting an indirect effect on T2D risk through its
relationship with BMI (7,8). Concerning anthropometry, the assessment
of genome-wide contributions of common variants to waist-to-hip ratio
(WHR) and WHR adjusted for BMI are examples of association studies
where relatively simple anthropometric measurements have been refined
through either subtype or adjustment and have yielded novel genome-
wide association profiles (10,11).
Although BMI was designed to assess weight independent of height,
it remains correlated with height owing to its generalized derivation.
This correlation changes throughout the life course and has the
potential to complicate inference and reduce power in association
studies. Targeting this well-known, but often ignored, limitation in
BMI as a measure for fat mass we aimed to assess the contribution
of common genetic variation to a height-adjusted version of that
phenotype which appropriately accounts for covariation in height in
children. Using data available from the Avon Longitudinal Study of
Parents and Children (ALSPAC) study, we set out to undertake a
genome-wide association study (GWAS) for a height-adjusted ver-
sion of BMI using the appropriate power function for minimizing
the correlation between BMI and height in the age group with the
largest correlation between weight and height.
Methods
ALSPAC
ALSPAC is a prospective birth cohort which recruited pregnant
women with expected delivery dates between April 1991 and
December 1992 from Bristol UK. About 14,541 pregnant women
were initially enrolled with 14,062 children born. Detailed informa-
tion on health and development of children and their parents were
collected from regular clinic visits and completion of questionnaires.
A detailed description of the cohort has been published previously
(12,13). Ethical approval was obtained from the ALSPAC Law and
Ethics Committee and the Local Ethics Committees. Please note that
the study website contains details of all the data that is available
through a fully searchable data dictionary (http://www.bris.ac.uk/
alspac/researchers/data-access/data-dictionary/).
A total of 9912 participants were genotyped using the Illumina
HumanHap550 quad genome-wide SNP genotyping platform. Quality
control assessment and imputation are described in Supporting Infor-
mation. After quality control assessment and imputation the data set
consisted of 8365 individuals 2,608,006 SNPs available for analysis.
Generation R
The Generation R Study is a population-based prospective cohort
study of pregnant women and their children from fetal life onwards in
Rotterdam, The Netherlands (16,17). All children were born between
April 2002 and January 2006, and currently followed until young
adulthood. Of all eligible children in the study area, 61% were partici-
pating in the study at birth. Anthropometric data were collected in sev-
eral developmental stages. Cord blood samples including DNA have
been collected at birth. The current study used the first set of Genera-
tion R samples of Northern European Ancestry.
Samples were genotyped using Illumina Infinium II HumanHap610
Quad Arrays following standard manufacturer’s protocols. Quality
control assessment and imputation are described in Supporting Infor-
mation. After quality control assessment and imputation 2729 chil-
dren and 2,543,887 SNPs were included in the analyses.
Phenotype calculation
For ALSPAC, we used measurements of height and weight at clinic vis-
its when the children were nine years of age to calculate BMI. Height
was measured to the last complete mm using the Harpenden Stadiome-
ter. A total of 5809 unrelated children had both anthropometric and
genetic data appropriate for our analysis. Their mean age was 9.9 years
(SD 0.3), the mean BMI was 17.7 (SD 2.8), mean height was 139.5 cm
(SD 6.3) and 50.5% were female. A Lunar prodigy narrow fan beam
densitometer was used to perform a whole body DXA (Dual-energy X-
ray absorptiometry) scan where bone content, lean and fat masses are
measured (18,19). BMI was also measured as above in Generation R at
regular intervals with the latest measurement used for this analysis
[mean age5 6.1 years (SD 0.4)]. A total of 2089 unrelated children had
both anthropometric and genetic data appropriate for our analysis with
mean BMI 15.9 (SD 1.4), mean height 119.5 cm (SD 5.6).
In ALSPAC, we defined height-adjusted BMI as BMI[x]5weight(kg)/
height(m)x). For each age group we calculated BMI[x] iteratively increas-
ing the power [x] term by 0.1 each time. We then measured the correla-
tion of each BMI[x] with height (within children of the same age group)
based on Pearson’s correlation coefficient. We selected the power term
that resulted in the lowest correlation coefficient of BMI[x] with height
for any given age. This approach yielded a value for BMI[x] which per-
formed equivalently to adjusting log BMI for log height (6), but which
reported the appropriate power term for each age group and thus the rela-
tive inefficiency of conventional BMI. In addition, we calculated zBMI,
which is a commonly used measure in clinical practice, by standardising
BMI by age and sex. Stata 12 was used for the calculations (20). In Gen-
eration R BMI was calculated as BMI5weight(kg)/height(m)2) and
height was included as a covariate in the GWAS model.
Statistical methods
Genomewide association analyses were performed using MACH2QTL
V110 (14,15). To investigate if the association at the adenylate
cyclase 3 (ADCY3) locus could be attributed to rs11676272,
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conditional analysis was performed by including the rs11676272 dose
generated during imputation in the regression model and conducting
regional single marker association analyses with BMI[3.1]. Age, sex,
height, and rs11676272 dose were included as covariates in the
model. Plots were generated using LocusZoom (21).
For the meta-analysis of BMI adjusted for height in ALSPAC and
Generation R samples, SNPs that had a minor allele frequency
<0.01 and an r2 imputation quality score <0.3 were excluded.
Meta-analysis was performed using METAL software package (22).
Sample size weighted analysis (based on P-values) was conducted.
We used the “Heterogeneity” command in METAL to assess evi-
dence of between study heterogeneity.
Body fat and lean mass were measured by whole body DXA in
5557 children during a clinic performed at age 9 as described above.
Data were log transformed and then z scores were calculated for the
transformed values assuming normality. Linear regressions were per-
formed with age, sex, and height as covariates in the two models. In
addition, bi-directional adjustment was performed with lean mass
included as a covariate in the model for body fat and body fat
included as a covariate in the model for lean mass. Association of
rs11676272 with both body fat and lean mass would suggest that the
height-adjusted BMI phenotype reflects changes in weight, while an
association with body fat alone would be expected if it reflects fat
mass specifically. Stata 12 was used for these calculations (20).
Expression
RNA was extracted from lymphoblastoid cell line (LCLs) generated
from 997 unrelated ALSPAC individuals of age 9, which were
included in the GWAS, using an RNeasy extraction kit (Qiagen) and
was amplified using the Illumina TotalPrep-96 RNA Amplification
kit (Ambion). Expression was evaluated using Illumina HT-12 v3
BeadChip arrays. Each individual sample was run with two repli-
cates. Expression data were normalized by quantile normalization
between replicates and then by median normalization across individ-
uals. For 949 ALSPAC individuals, both expression levels and
imputed genome-wide SNP data were available. We used linear
regression to investigate the association between rs11676272 and
any transcript within 500 kb of this SNP.
Genevar, a database and Java application for the analysis and visual-
ization of SNP-gene associations in eQTL studies (23), was used to
test for evidence of ADCY3 expression in public databases. ADCY3
expression was analyzed in data from 856 healthy female twins of
the Multiple Tissue Human Expression Resource (MuTHER)
resource in both adipose and lymphoblastoid cell lines (24).
Results
The height power x defining BMI[x] varied by age from infancy to
17 years (Figure 1). It was smallest at 12 months (x5 1.5) and larg-
est at 8-12 years (x5 3.1), this latter period being the time when
BMI[x] and BMI (with x5 2) were most different. This is also illus-
trated by the correlation of standard BMI with height which was
maximum during infancy and remained high until 13 years when
puberty commences (Supporting Information Figure S1). zBMI also
suffers the same problem of correlation with height as BMI (Sup-
porting Information Figure S2).
Selecting 8-12 years as the age which both maximises sample size
and exploit the difference between BMI[x] and BMI, we performed
a GWAS of BMI[x] with x5 3.1, adjusted for age and sex, where x
was estimated from 5809 nonrelated participants seen at the age 9
clinic visits of the ALSPAC study (mean age5 9.9 years). The
strongest signal of association between genetic variation and
BMI[3.1] was rs1558902 at FTO (0.21 kg/m3.1 change per allele A
(0.13, 0.27), P5 9 3 10210, minor allele frequency (MAF) A5 0.4)
(Figure 2a). However, a similar effect was found for rs11676272
(0.20 kg/m3.1 change per allele G (0.13, 0.27), P5 4 3 1029, MAF
G5 0.48), a nonsynonymous SNP located in the first exon of
ADCY3 resulting in a serine-to-proline substitution in the second
transmembrane helix of the expressed protein.
For variation at SNPs across the ADCY3 locus and conventional BMI
there was not genome-wide significant evidence for association (Fig-
ure 2b) [rs11676272 (0.25 kg/m2 (0.15, 0.35), P5 6 3 1027)]. zBMI
(BMI standardised for age) was not associated with rs11676272
[0.022 change in zBMI per allele G (20.01 to 0.06), P5 0.224)]. In
contrast, the association of rs1558902 in FTO remained genome-wide
significant [0.33 kg/m2 (0.23, 0.43), P5 1 3 10210]. Evidence for
association at the ADCY3 locus and rs11676272 [0.28 kg/m2 (0.19,
0.38), P5 6 3 1029] remained genome-wide significant, as expected,
when performing a GWAS on conventional BMI adjusted for height
(Figure 2c). Furthermore, in sensitivity analyses performing regional
single marker association analyses with BMI adjusted for height con-
ditional on rs11676272 dose, all evidence for association across the
ADCY3 region was lost (Figure 3).
There was consistent evidence of association for rs11676272 with
BMI adjusted for height [0.14 kg/m2 (0.06, 0.22), P5 0.0001] in
2089 nonrelated children from Generation R (mean age5 6.1 years).
This time point in Generation R children was selected as it was the
latest age available and the closest to children of age nine in
ALSPAC. A meta-analysis of BMI adjusted for height in ALSPAC
and Generation R samples provided additional evidence for associa-
tion between rs11676272 and BMI adjusted for height (Figure 2d).
Figure 1 Power term [x] required for the least correlation of BMI[x]5weight/(height)x
with height. This is reflected by the correlation coefficient across different age
groups in all children from the Avon Longitudinal Study of Parents and Children
(ALSPAC) study and stratified by sex. [Color figure can be viewed in the online
issue, which is available at wileyonlinelibrary.com.]
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Figure 2 Manhattan plots of the results from genome-wide association studies (GWAS) on BMI. (a) ALSPAC GWAS on BMI[3.1] adjusted for sex and age, (b)
ALSPAC GWAS on BMI adjusted for sex and age, (c) ALSPAC GWAS on BMI adjusted for sex, age, and height, and (d) meta-analysis of ALSPAC and Generation R
GWAS on BMI adjusted for sex, age, and height. [Avon Longitudinal Study of Parents and Children (ALSPAC)].
Figure 3 Regional plots in ADCY3(adenylate cyclase 3) locus showing that the association at the locus is attributed to rs11676272. (a) BMI adjusted for height, age and
sex in ALSPAC, (b) BMI adjusted for height, age and sex conditioning on rs11676272 in ALSPAC. Each circle represents a SNP plotted by its position on the chromo-
some against its association (2log10 P). The SNPs are colored according to their linkage disequilibrium (LD) with rs11676272 using pairwise r2 values from HapMap
CEU samples. The diagram in light blue represents the LD structure in the region. Data for gene structure from UCSC Genome Browser are shown below the diagram.
Plots were generated using LocusZoom (22) [Avon Longitudinal Study of Parents and Children (ALSPAC)].
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Again, the phenotypic association across this region of chromosome
2 was ablated when adjusted for rs11676272 dose.
Unlike the age-dependent association of FTO and BMI (25) the
association of ADCY3 with BMI[x] was consistent across age. The
strength of association of rs11676272 with BMI[x] at age 7 (x5 2.8)
was similar to that at age 9 [0.17 kg/m2.8 (0.11, 0.23), P5 9 3
1029] while as expected (25), the association of rs9939609 in FTO
was weaker in younger children [age 7: 0.09 kg/m2.8 (0.03, 0.15),
P5 0.002].
rs11676272 was strongly associated with total fat mass with height in
the model [0.11 kg (0.08, 0.14), P5 7 3 10212], but adding lean mass
to the model made no difference [0.1 kg (0.07, 0.13), P5 6 3 10211].
Furthermore, lean mass was only weakly associated with variation at
rs1167612 [0.02 kg (0.001, 0.041), P5 0.04], disappearing completely
when adjusted for body fat (0.00 kg (20.02, 0.02), P5 0.8). The cor-
relation of BMI[3.1] with fat mass (r5 0.84) was far stronger than
with lean mass (r5 0.31) (Supporting Information Figure S3).
In contrast to the association of ADCY3 with BMI[3.1] and total fat
mass, rs11676272 was not associated with height in ALSPAC
[20.19 cm (20.41, 0.03), P5 0.1] while the SNP in the ADCY3
region best associated with height was rs2918630 [0.30 cm (0.08,
0.53), P5 0.008].
Analysis of ADCY3 expression in lymphoblastoid cell lines showed
a strong association between the rare (adiposity increasing) variant
G at rs11676272 and reduced levels of ADCY3 expression [20.65
SD per allele (20.74, 20.57), P5 1 3 10253]. Conditioning on
rs11676272 dose abolished this association, reducing the variance in
expression levels explained by each SNP from r25 0.21 to r2< 0.01
(Figure 4). In MuTHER study data, expression analyses showed
strong evidence of ADCY3 expression in both adipose (Supporting
Information Figure S4 and Table S1) and lymphoblastoid cell
lines (Supporting Information Figure S5 and Table S2) (24) with the
rare variant G at rs11676272 associated with reduced levels of
expression in adipose tissue [20.1 SD per allele (20.08, 20.13),
P5 4 3 1028).
Figure 4 Genetic and expression data on the ADCY3 (adenylate cyclase 3) locus.
Overlay of the GWAS on BMI adjusted for height results (left axis and grey spikes),
the GWAS on BMI adjusted for height conditioning on rs11676272 dose (left axis
and black spikes), the association of the expression of ADCY3 by the same var-
iants in the region (expressed as r2 on the right axis and green dots) and the resid-
ual variation in expression after regression on rs11676272 (orange dots). The
diamonds indicate the position of rs11676272 p values for the test for association
with BMI adjusted for height (top diamond) and gene expression results expressed
as r2 (bottom diamond).
Figure 5 Regional plot for ADCY3 (adenylate cyclase 3) locus with ALSPAC and the Genetic Investigation of ANthropo-
metric Traits (GIANT) meta-analysis data (11). Green circles represent SNPs and their association with BMI[3.1] in
ALSPAC and orange circles represent SNPs and their association with BMI in the GIANT meta-analysis. rs11676272 is
indicated by a diamond. [Avon Longitudinal Study of Parents and Children (ALSPAC)].
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Discussion
BMI is a widely accepted though imperfect index of weight for
height, which is complicated by differential performance in certain
body types and age groups. We used GWAS to investigate the con-
tribution of common variants to an index of weight (and equiva-
lently BMI) uncorrelated with height in children of age 9 from the
ALSPAC study. A missense variant, rs11676272, in ADCY3 showed
evidence of genome-wide significance only when height was
adjusted for, and this result was replicated in an independent sample
of children from the Generation R study.
Our results using BMI[x] highlight the importance of the timing of
puberty for height and weight measurements (26,27). During puberty
the correlation between weight and height increases, so weight
adjusted for height requires a larger height power, as seen in Figure 1
(6). This arises because both weight and height are temporarily greater
in earlier than later maturers, which stretches the joint distribution.
BMI only partially adjusts weight for height, so it includes a residual
height signal which means that BMI is also raised in early maturers.
However, if weight is fully adjusted for height (i.e. using BMI[x]) the
residual height signal is largely abolished, and BMI[x] is much closer
to a measure of adiposity independent of the timing of puberty. The
same limitation is also found in zBMI, which, although takes age and
sex into account, is still correlated with height.
This is relevant because our previous work (27) found that the rela-
tion between BMI and FTO related at least in part to developmental
age, i.e. that children with the obesity-variant had an earlier adipos-
ity rebound, a predictor of later obesity. By using BMI[x] rather
than BMI we have reduced (though not removed) the developmental
age signal, which has allowed the adiposity signal to emerge via its
association with the ADCY3 locus. In this case, signals at loci such
as ADCY3 fall into a new category of signals for BMI in the
absence of coincident correlations with height that may suggest that
they are having a more basal adiposity effect and one which should
be more consistent with time.
The ADCY3 locus has been implicated in genetic studies of body
weight and height before. SNPs in the ADCY3 gene were associated
with obesity in a sample of Swedish men with and without type 2
diabetes (28). This locus, though not this variant, was found to be
associated with BMI in the GIANT (Genetic Investigation of
ANthropometric Traits) consortium meta-analysis (rs10182181,
P5 1.83 1027, r2(with rs11676272)5 0.97) (29) and also in a meta-
analysis of non- European populations (rs6545814, P5 1.353 10213,
Figure 6 In situ hybridization data from the Allen Mouse Brain Atlas. Darker staining is seen in coronal sections of adult mouse
brains indicating ADCY3 (adenylate cyclase 3) mRNA expression within the hypothalamus, including the (a) suprachiasmatic, (b)
paraventricular, (c) ventromedial, and (d) arcuate nucleus. Data from Allen Mouse Brain Atlas (35) (http://mouse.brainmap.org/
experiment/ivt?id575&popup5true). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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r2 (with rs11676272)5 0.8) (30). Unlike the 5000 children that were
used in our study, both of these studies had sample sizes exceeding
120,000 individuals. Furthermore, the signal reported at rs11676272
(i.e. a directly implicated functional variant) presented weak evidence
(consistent with chance) in the basic large-scale meta-analyses for
BMI undertaken in the GIANT investigation (rs11676272: P5 9.3 3
1025) despite the size of the study (Figure 5).
ADCY3 codes for the membrane-associated enzyme adenyl cyclase
3, which catalyses the synthesis of cAMP from ATP (31). The
ACDY3 protein sequence comprises two clusters of membrane span-
ning helices, called M1 and M2, which interact to bring together a
large cytosolic intracellular loop with a region at the C-terminus to
form a composite and competent catalytic domain (32). The serine-
to-proline substitution coded by rs11676272 lies within the second
transmembrane spanning alpha-helix of the M1 cluster. In addition
to the observed association with reduced expression of ADCY3, we
suggest that the proline substitution could disrupt the interaction
between helix bundle M1 and M2 leading to a reduction in adenyl
cyclase activity.
In situ hybridization data from the Allen Mouse Brain Atlas (33),
which integrates extensive gene expression and neuroanatomical data,
show ADCY3 mRNA expression in the mouse brain within several
nuclei of the hypothalamus, including the paraventricular, ventrome-
dial, and arcuate nucleus (Figure 6) (33,34), regions that are involved
in central regulation of energy homeostasis. ADCY3 knockout mice
exhibit age-dependent obesity, which was attributed to hyperphagia,
low locomotor activity, and leptin insensitivity and demonstrated to
be most likely because of hypothalamic cAMP reductions (35).
The strength of our study is in the availability of cross-sectional
anthropometric data at multiple time points for a large number of
children. It enabled us to identify that variation in ADCY3 is associ-
ated with body fat rather than lean mass or height in the ALSPAC
sample. Variation at ADCY3 has been associated with height
(rs4665736, P5 1.44 3 10213 in the GIANT meta-analysis for
height) (36). However, in children of age 9 from the ALSPAC study
rs11676272 was not associated with height [20.189cm change per
allele G (20.041,0.034), P5 0.098].
Conclusion
We have identified a functional polymorphism that is associated
with fat mass in childhood with an effect size comparable to common
variation at the FTO locus, however, only when height is correctly
taken into account. In the general context of several limitations of BMI
(i.e. age, ethnicity, body composition), our work highlights the potential
impact to analytical precision/power associated with na€ıve use of BMI.
In this investigation of height-adjusted BMI we have been able to show,
in addition to limited available evidence, strong association with func-
tional variation at ADCY3. Currently, it is not clear how this polymor-
phism can lead to the increased body fat observed, though effects could
be directly on adipose tissue, triglyceride metabolism and/or the result
of a centrally-mediated hyperphagic response.O
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